Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Non-small Cell Lung Cancer (qRT-PCR)

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

OTHER RELATED OMICS DATASETS IN: PRJNA108781PRJNA153537PRJNA108779PRJNA108429PRJNA107251

ORGANISM(S): Homo sapiens

PROVIDER: GSE10939 | GEO | 2009/10/01

SECONDARY ACCESSION(S): PRJNA107251

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

INO80 is required for oncogenic transcription and tumor growth in non-small cell lung cancer

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2016-08-03 | E-GEOD-85119 | biostudies-arrayexpress

Antagonizing miR-128 abrogates chemoresistance-associated metastasis and is therapeutic in non-small cell lung cancer

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2015-04-10 | E-GEOD-67729 | biostudies-arrayexpress

Affymetrix microarray and qRT-PCR expression profile of HEK293 cells stably transfected with PRL-1 (PTP4A1) or empty pcDNA4 vector (control)

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2013-07-30 | E-GEOD-42588 | biostudies-arrayexpress

Comparative Analysis of TTF-1 Binding DNA Regions in Small Cell Lung Cancer and Non-Small Cell Lung Cancer

Project description:This SuperSeries is composed of the SubSeries listed below.

2019-11-30 | GSE129341 | GEO

Targeting TIP60 inhibits tumorigenesis in non-small cell lung cancer

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-05-08 | GSE207203 | GEO

Real-time quantitative PCR analysis of mice lung tissue

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2013-11-26 | E-GEOD-52720 | biostudies-arrayexpress

Comprehensive Analysis of Recurrence-Associated Small Non-Coding RNAs in Esophageal Cancer

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2016-06-30 | E-GEOD-55857 | biostudies-arrayexpress

High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.

Project description:Validation of biomarkers is essential to advance the translational process to clinical application. Although there exists an increasing number of reports on small non-coding RNAs (microRNAs) as minimally-invasive markers from blood, serum or plasma, just a limited number is verified in follow-up studies. We used qRT-PCR to evaluate a known miRNA signature measured from blood that allowed for separation between patients with non-small cell lung cancer (NSCLC), COPD and healthy controls.From the data of our previous microarray studies we selected a panel of 235 miRNAs related to lung cancer and COPD. We observed a high concordance between the AUC values of our initial microarray screening and the qRT-PCR data (correlation of 0.704, p < 10-16). Overall, 90.3% of markers were successfully validated. Among the top markers that were concordant between both studies we found hsa-miR-20b-5p, hsa-miR-20a-5p, hsa-miR-17-5p, and hsa-miR-106a-5p. The qRT-PCR analysis also confirmed that non-small cell lung cancer patients could be accurately differentiated from unaffected controls: a subset of five markers was sufficient to separate NSCLC patients from unaffected controls with accuracy of 94.5% (specificity and sensitivity of 98% and 91%). Beyond differentiation from controls, we also succeeded in separating NSCLC patients from patients with COPD. MiRNAs that were identified as relevant for the separation between lung cancer and COPD by both qRT-PCR and the array-based studies included hsa-miR-26a-5p, hsa-miR-328-3p and hsa-miR-1224-3p. Although for differentiation between NSCLC patients from COPD patients more markers were required, still high accuracy rates were obtained (5 markers: 78.8%; 10 markers: 83.9%; 50 markers: 87.6%).

| S-EPMC4826230 | biostudies-literature

Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2014-10-23 | E-GEOD-62614 | biostudies-arrayexpress

NRF2-dependent transcriptome and H3K27ac distribution in non-small cell lung cancer

Project description:This SuperSeries is composed of the SubSeries listed below.

2020-09-23 | GSE118844 | GEO